Further investigation revealed that ZIKV infection upregulated expression of NKG2D ligands on target cells, and that blocking γδ T cell-mediated cytotoxicity against target cells can be achieved using NKG2D antibodies [42] (Fig 1B). The gene discussed is KLRK1; the disease is Zika virus infectious disease.